Back
HFA Premium Access

Efficacy and safety of selexipag in patients with pulmonary arterial hypertension in real-life: early results of RAMPHA study

Session: Focus on the right side
Topic: Pulmonary Hypertension
Speaker: Doctor R. Bravo-Marques (Marbella, ES)
Event: Heart Failure 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Rafael Bravo-Marques

University Hospital Costa del Sol, Marbella (Spain)
0 follower

6 more presentations in this session

Myocardial work in different aetiologies of right ventricular hemodynamic overload

Speaker: Mr K. Berg-Hansen (Aarhus, DK)

Access
Abstract
Like
Thumbnail

Feasibility and safety of the antecubital venous access for right heart catheterization in patients with pulmonary hypertension

Speaker: Doctor J. Grade Santos (Almada, PT)

Access
Abstract
Slides
Like
Thumbnail

COMPERA score revised: better risk estimation to better tailor therapeutics in precapillary hypertension

Speaker: Doctor P. Alves da Silva (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Comparison of different clinical prognostic scores in patients with pulmonary embolism and active cancer

Speaker: Doctor A. Martins (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Dexamethasone treatment attenuates pulmonary embolism rates in severe COVID-19 disease

Speaker: Doctor P. Jirak (Salzburg, AT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Focus on the right side

Speakers: Doctor R. Bravo-Marques, Mr K. Berg-Hansen, Doctor J. Grade Santos, Doctor P. Alves da Silva, Doctor A. Martins...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources